Literature DB >> 35604216

The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.

Jonas L Delva1, Cliff Van Waesberghe1, Wim Van Den Broeck2, Jochen A Lamote3, Nick Vereecke1, Sebastiaan Theuns1, Liesbeth Couck2, Herman W Favoreel1.   

Abstract

Pseudorabies virus (PRV) is a porcine alphaherpesvirus and the causative agent of Aujeszky's disease. Successful eradication campaigns against PRV have largely relied on the use of potent PRV vaccines. The live attenuated Bartha strain, which was produced by serial passaging in cell culture, represents one of the hallmark PRV vaccines. Despite the robust protection elicited by Bartha vaccination, very little is known about the immunogenicity of the Bartha strain. Previously, we showed that Bartha-infected epithelial cells trigger plasmacytoid dendritic cells (pDC) to produce much higher levels of type I interferons than cells infected with wild-type PRV. Here, we show that this Bartha-induced pDC hyperactivation extends to other important cytokines, including interleukin-12/23 (IL-12/23) and tumor necrosis factor alpha (TNF-α) but not IL-6. Moreover, Bartha-induced pDC hyperactivation was found to be due to the strongly increased production of extracellular infectious virus (heavy particles [H-particles]) early in infection of epithelial cells, which correlated with a reduced production of noninfectious light particles (L-particles). The Bartha genome is marked by a large deletion in the US region affecting the genes encoding US7 (gI), US8 (gE), US9, and US2. The deletion of the US2 and gE/gI genes was found to be responsible for the observed increase in extracellular virus production by infected epithelial cells and the resulting increased pDC activation. The deletion of gE/gI also suppressed L-particle production. In conclusion, the deletion of US2 and gE/gI in the genome of the PRV vaccine strain Bartha results in the enhanced production of extracellular infectious virus in infected epithelial cells and concomitantly leads to the hyperactivation of pDC. IMPORTANCE The pseudorabies virus (PRV) vaccine strain Bartha has been and still is critical in the eradication of PRV in numerous countries. However, little is known about how this vaccine strain interacts with host cells and the host immune system. Here, we report the surprising observation that Bartha-infected epithelial porcine cells rapidly produce increased amounts of extracellular infectious virus compared to wild-type PRV-infected cells, which in turn potently stimulate porcine plasmacytoid dendritic cells (pDC). We found that this phenotype depends on the deletion of the genes encoding US2 and gE/gI. We also found that Bartha-infected cells secrete fewer pDC-inhibiting light particles (L-particles), which appears to be caused mainly by the deletion of the genes encoding gE/gI. These data generate novel insights into the interaction of the successful Bartha vaccine with epithelial cells and pDC and may therefore contribute to the development of vaccines against other (alphaherpes)viruses.

Entities:  

Keywords:  Aujeszky’s disease virus; Bartha; Bartha-K61; PRV; US2; gE/gI; glycoprotein E; glycoprotein I; interferon; pDC; plasmacytoid dendritic cell; plasmacytoid dendritic cells; pseudorabies virus; suid herpesvirus 1

Mesh:

Substances:

Year:  2022        PMID: 35604216      PMCID: PMC9215243          DOI: 10.1128/jvi.02199-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  91 in total

Review 1.  Cell biological and molecular characteristics of pseudorabies virus infections in cell cultures and in pigs with emphasis on the respiratory tract.

Authors:  Hans Nauwynck; Sarah Glorieux; Herman Favoreel; Maurice Pensaert
Journal:  Vet Res       Date:  2007-01-25       Impact factor: 3.683

2.  Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells.

Authors:  T Ben-Porat; J DeMarchi; J Pendrys; R A Veach; A S Kaplan
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Role of pseudorabies virus Us3 protein kinase during neuronal infection.

Authors:  L M Olsen; T H Ch'ng; J P Card; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Genetic basis of the neurovirulence of pseudorabies virus.

Authors:  B Lomniczi; S Watanabe; T Ben-Porat; A S Kaplan
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

5.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha.

Authors:  B G Klupp; B Lomniczi; N Visser; W Fuchs; T C Mettenleiter
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

7.  Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12.

Authors:  Laurence Guzylack-Piriou; Carole Balmelli; Kenneth C McCullough; Artur Summerfield
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

8.  Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity.

Authors:  T G Kimman; N de Wind; N Oei-Lie; J M Pol; A J Berns; A L Gielkens
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

Review 9.  Tegument Assembly and Secondary Envelopment of Alphaherpesviruses.

Authors:  Danielle J Owen; Colin M Crump; Stephen C Graham
Journal:  Viruses       Date:  2015-09-18       Impact factor: 5.048

10.  Comparison of Pathogenicity-Related Genes in the Current Pseudorabies Virus Outbreak in China.

Authors:  Yan-Dong Tang; Ji-Ting Liu; Tong-Yun Wang; Ming-Xia Sun; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.